| The human 26S Proteasome at 6.8 Ang. | |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 1-234 | 100 | |
|
| Human 19S-20S proteasome, state SD2 | |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 1-234 | 100 | 4×ATP; 6×LDZ; 1×ZN; |
|
| Human premature 20S proteasome assembly intermediate | |
Heteromer O14818; O95456; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q969U7; Q99436; Q9Y244; | 1-234 | 100 | |
|
| Human Constitutive 20S Proteasome | |
Heteromer O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | 2-234 | 100 | |
|
| Crystal Structure of the mammalian 20S proteasome at 2.75 A resolution | |
Heteromer P33672; Q2TBP0; Q2TBX6; Q2YDE4; Q32KL2; Q3MHN0; Q3T0X5; Q3T0Y5; Q3T108; Q3ZBG0; Q3ZCK9; Q58DU5; Q5E987; Q5E9K0; | 2-234 | 100 | 30×MG; |
|
| Human constitutive 20S proteasome in complex with carfilzomib | |
Heteromer O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | 2-234 | 100 | 6×3BV; |
|
| The human PI31 complexed with bovine 20S proteasome | |
Heteromer P33672; Q2TBP0; Q2TBX6; Q2YDE4; Q32KL2; Q3MHN0; Q3SX30; Q3T0X5; Q3T0Y5; Q3T108; Q3ZBG0; Q3ZCK9; Q58DU5; Q5E987; Q5E9K0; | 1-233 | 100 | |
|
| The PI31-free Bovine 20S proteasome | |
Heteromer P33672; Q2TBP0; Q2TBX6; Q2YDE4; Q32KL2; Q3MHN0; Q3T0X5; Q3T0Y5; Q3T108; Q3ZBG0; Q3ZCK9; Q58DU5; Q5E987; Q5E9K0; | 1-233 | 100 | |
|
| Structural basis for dynamic regulation of the human 26S proteasome | |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 2-234 | 100 | 6×ATP; 1×ZN; |
|
| Structural basis for dynamic regulation of the human 26S proteasome | |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 2-234 | 100 | 4×ATP; 1×ZN; |
|
| Human pre 13S proteasome assembly intermediate | |
Heteromer O14818; O95456; P25786; P25788; P25789; P28066; P49720; P49721; P60900; Q969U7; Q99436; Q9Y244; | 1-233 | 100 | |
|
| Human mixed 13S proteasome assembly intermediate | |
Heteromer O14818; O95456; P25786; P25788; P25789; P28066; P49720; P49721; P60900; Q969U7; Q99436; Q9Y244; | 2-234 | 100 | |
|
| The human 26S proteasome at 3.9 A | |
Heteromer O14818; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P49720; P49721; P60900; P62191; P62195; P62333; Q99436; | 2-234 | 100 | 5×ATP; 5×MG; 1×ADP; |
|
| Structure of the human 26S proteasome bound to USP14-UbAl | |
Heteromer O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 2-234 | 100 | 6×ADP; |
|
| Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… | |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 3-234 | 100 | 1×ZN; |
|
| Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… | |
Heteromer O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | 3-234 | 100 | |
|
| Proteasome-ZFAND5 Complex Z+B state | |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 3-234 | 100 | 1×ZN; 4×ATP; 5×MG; 2×ADP; |
|
| SD-like state of human 26S Proteasome with non-cleavable M1-linked hexaubiquitin and E3 ubiquitin l… | |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 3-234 | 100 | 1×ZN; 4×AGS; |
|
| Proteasome-ZFAND5 Complex Z-C state | |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 3-234 | 100 | 1×ZN; 4×ATP; 5×MG; 1×ADP; |
|
| Structural basis for dynamic regulation of the human 26S proteasome | |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 3-234 | 100 | 6×ADP; 1×ZN; |
|
| Proteasome-ZFAND5 Complex Z+A state | |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 3-234 | 100 | 1×ZN; 4×ATP; 5×MG; 2×ADP; |
|
| Human 20S proteasome assembly intermediate structure 5 | |
Heteromer O14818; O95456; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q969U7; Q99436; Q9Y244; | 3-234 | 100 | |
|
| Structure of human constitutive 20S proteasome complexed with the inhibitor TDI-8304 | |
Heteromer O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | 3-234 | 100 | 2×YRE; |
|
| Proteasome-ZFAND5 Complex Z-A state | |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 3-234 | 100 | 1×ZN; 5×ATP; |
|
| Proteasome-ZFAND5 Complex Z+C state | |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 3-234 | 100 | 1×ZN; 4×ATP; 5×MG; 2×ADP; |
|
| Proteasome-ZFAND5 Complex Z+E state | |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 3-234 | 100 | 1×ZN; 4×ATP; 5×MG; 2×ADP; |
|
| Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome | |
Heteromer O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 3-234 | 100 | 1×ZN; 4×ATP; 5×MG; 2×ADP; |
|
| Structural basis for dynamic regulation of the human 26S proteasome | |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 3-234 | 100 | 4×ATP; 1×ZN; |
|
| Structure of USP14-bound human 26S proteasome in substrate-inhibited state SC_USP14 | |
Heteromer A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 3-234 | 100 | 4×ATP; 2×ADP; 1×ZN; |
|
| SA-like state of human 26S Proteasome with non-cleavable M1-linked hexaubiquitin and E3 ubiquitin l… | |
Heteromer A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG48; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 3-234 | 100 | 1×ZN; 4×AGS; 5×MG; 2×ADP; |
|
| Structure of USP14-bound human 26S proteasome in substrate-inhibited state SB_USP14 | |
Heteromer A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 3-234 | 100 | 4×ATP; 2×ADP; 1×ZN; |
|
| Structure of USP14-bound human 26S proteasome in state EA1_UBL | |
Heteromer A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 3-234 | 100 | 4×ATP; 6×MG; 2×ADP; 1×ZN; |
|
| Structure of USP14-bound human 26S proteasome in substrate-inhibited state SD4_USP14 | |
Heteromer A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 3-234 | 100 | 2×ADP; 2×ATP; 1×ZN; |
|
| Structure of USP14-bound human 26S proteasome in substrate-inhibited state SD5_USP14 | |
Heteromer A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 3-234 | 100 | 3×ATP; 1×ADP; 1×ZN; |
|
| Proteasome-ZFAND5 Complex Z-B state | |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 3-234 | 100 | 1×ZN; 4×ATP; |
|
| Structure of USP14-bound human 26S proteasome in state EA2.0_UBL | |
Heteromer A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 3-234 | 100 | 4×ATP; 6×MG; 2×ADP; 1×ZN; |
|
| Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome | |
Heteromer O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 3-234 | 100 | 1×ZN; 4×ATP; 5×MG; 2×ADP; |
|
| Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… | |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 3-234 | 100 | 1×ZN; 4×AGS; |
|
| Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome | |
Heteromer O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 3-234 | 100 | 1×ZN; 2×ADP; 3×ATP; 3×MG; |
|
| Structure of USP14-bound human 26S proteasome in state EA2.1_UBL | |
Heteromer A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 3-234 | 100 | 4×ATP; 5×MG; 2×ADP; 1×ZN; |
|
| Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… | |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 3-234 | 100 | 1×ZN; |
|
| Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… | |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 3-234 | 100 | 1×ZN; 4×AGS; |
|
| Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… | |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 3-234 | 100 | 1×ZN; 6×AGS; |
|
| Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… | |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 3-234 | 100 | 1×ZN; 4×AGS; |
|
| Structure of USP14-bound human 26S proteasome in substrate-engaged state ED4_USP14 | |
Heteromer A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 3-234 | 100 | 2×ADP; 4×ATP; 1×ZN; |
|
| Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome | |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 3-234 | 100 | 1×ZN; 4×ATP; 5×MG; 1×ADP; |
|
| Structure of USP14-bound human 26S proteasome in substrate-engaged state ED1_USP14 | |
Heteromer A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 3-234 | 100 | 4×ATP; 1×ADP; 1×ZN; |
|
| Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome | |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 3-234 | 100 | 1×ZN; 3×ATP; 1×ADP; |
|
| Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome | |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 3-234 | 100 | 1×ZN; 4×ATP; 4×MG; 1×ADP; |
|
| Structure of USP14-bound human 26S proteasome in substrate-engaged state ED2.0_USP14 | |
Heteromer A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 3-234 | 100 | 4×ATP; 1×ADP; 1×ZN; |
|
| Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome | |
Heteromer O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 3-234 | 100 | 1×ZN; 3×ATP; 3×MG; 2×ADP; |
|
| Structure of USP14-bound human 26S proteasome in substrate-engaged state ED2.1_USP14 | |
Heteromer A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 3-234 | 100 | 4×ATP; 4×MG; 1×ADP; 1×ZN; |
|
| Structure of USP14-bound human 26S proteasome in substrate-engaged state ED0_USP14 | |
Heteromer A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 3-234 | 100 | 3×ATP; 2×ADP; 1×ZN; |
|
| Structure of USP14-bound human 26S proteasome in substrate-engaged state ED5_USP14 | |
Heteromer A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 3-234 | 100 | 3×ATP; 1×ADP; 1×ZN; |
|
| Proteasome-ZFAND5 Complex Z+D state | |
Heteromer O00231; O00232; O00487; O14818; O43242; O76080; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 3-234 | 100 | 1×ZN; 3×ATP; 3×MG; 2×ADP; |
|
| Nub1/Fat10-processing human 26S proteasome | |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P25786; P25788; P25789; P28066; P35998; P43686; P48556; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; Q9Y5A7; | 3-234 | 100 | 5×MG; 3×ATP; 3×ADP; 1×ZN; |
|
| bovine 20S immunoproteasome | |
Heteromer P33672; Q2TBX6; Q2YDE4; Q3SZC2; Q3T0T1; Q3T0X5; Q3T0Y5; Q3T108; Q3T112; Q3ZBG0; Q3ZCK9; Q58DU5; Q5E987; Q5E9K0; | 4-234 | 100 | |
|
| Human 20S proteasome assembly intermediate structure 2 | |
Heteromer O14818; O95456; P25786; P25788; P25789; P28066; P49720; P60900; Q969U7; Q99436; Q9Y244; | 3-233 | 100 | |
|
| Akirin2 bound human proteasome | |
Heteromer O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q53H80; Q99436; | 3-233 | 100 | 3×K; |
|
| Native human 20S proteasome at 1.8 Angstrom | |
Heteromer O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | 4-233 | 100 | 57×CL; 9×1PE; 6×K; 10×MG; |
|
| Human 20S proteasome complex with Oprozomib at 1.9 Angstrom | |
Heteromer O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | 4-233 | 100 | 58×CL; 6×K; 10×MG; 9×1PE; |
|
| Human 20S proteasome complex with Delanzomib at 2.0 Angstrom | |
Heteromer O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | 4-233 | 100 | 52×CL; 8×K; 10×MG; 9×1PE; 4×6V7; |
|
| Human 20S proteasome complex with Ixazomib at 2.0 Angstrom | |
Heteromer O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | 4-233 | 100 | 51×CL; 6×K; 10×MG; 9×1PE; 6×6V8; |
|
| Human 20S proteasome complex with Dihydroeponemycin at 2.0 Angstrom | |
Heteromer O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | 4-233 | 100 | 56×CL; 6×K; 10×MG; 9×1PE; 6×6VC; |
|
| Human 20S proteasome complex with Z-LLY-ketoaldehyde at 2.1 Angstrom | |
Heteromer O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | 4-233 | 100 | 55×CL; 8×NEN; 6×K; 10×MG; 9×1PE; |
|
| Human 20S proteasome complex with Bortezomib at 2.1 Angstrom | |
Heteromer O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | 4-233 | 100 | 51×CL; 6×K; 10×MG; 9×1PE; 6×BO2; |
|
| Human 20S proteasome complex with Oprozomib in Mg-Acetate at 2.2 Angstrom | |
Heteromer O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | 4-233 | 100 | 6×K; 10×MG; 9×1PE; 4×ACT; |
|
| Native human 20S proteasome in Mg-Acetate at 2.2 Angstrom | |
Heteromer O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | 4-233 | 100 | 6×K; 9×MG; 9×1PE; |
|
| Human 20S proteasome complex with Epoxomicin at 2.4 Angstrom | |
Heteromer O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | 4-233 | 100 | 58×CL; 6×K; 10×MG; 9×1PE; |
|
| Human PA200-20S proteasome with MG-132 | |
Heteromer O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q14997; Q99436; | 4-233 | 100 | 6×LDZ; 2×IHP; |
|
| Endogeneous native human 20S proteasome | |
Heteromer O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | 4-233 | 100 | |
|
| Cryo-EM structure of human immunoproteasome with a novel noncompetitive inhibitor that selectively … | |
Heteromer O14818; P20618; P25786; P25788; P25789; P28062; P28065; P28066; P28070; P40306; P49720; P49721; P60900; | 4-233 | 100 | 2×BZ7; |
|
| Human 20S proteasome assembly intermediate structure 3 | |
Heteromer O14818; O95456; P25786; P25788; P25789; P28066; P49720; P49721; P60900; Q969U7; Q99436; Q9Y244; | 4-233 | 100 | |
|
| human PA200-20S complex | |
Heteromer O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q14997; Q99436; | 4-233 | 100 | 1×K0W; 1×IHP; |
|
| PA28alpha-beta in complex with immunoproteasome | |
Heteromer P33672; Q06323; Q2TBX6; Q2YDE4; Q3SZC2; Q3T0T1; Q3T0X5; Q3T0Y5; Q3T108; Q3T112; Q3ZBG0; Q3ZCK9; Q58DU5; Q5E987; Q5E9K0; Q9UL46; | 5-234 | 100 | |
|
| Human PA200-20S proteasome complex | |
Heteromer O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q14997; Q99436; | 4-233 | 100 | 1×IHP; |
|
| Human 26S proteasome in complex with Oprozomib | |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q15008; Q99436; Q99460; Q9UNM6; | 4-233 | 100 | 6×ADP; |
|
| Non-substrate-engaged human 26S proteasome with Nub1/FAT10 bound to Rpn1 | |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P25786; P25788; P25789; P28066; P35998; P43686; P48556; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; Q9Y5A7; | 5-234 | 100 | 1×ADP; 6×MG; 5×ATP; 1×ZN; |
|
| Human 20S Proteasome in complex with peptide activator peptide BLM42 | |
Heteromer O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | 4-232 | 100 | 54×CL; 10×MG; 9×1PE; 6×K; |
|
| HUMAN IMMUNOPROTEASOME 20S PARTICLE IN COMPLEX WITH [(1R)-2-(1-benzofuran-3-yl)-1-{[(1S,2R,4R)-7-ox… | |
Heteromer O14818; P20618; P25786; P25788; P25789; P28062; P28065; P28066; P28070; P40306; P49720; P49721; P60900; | 5-233 | 100 | 13×NA; 11×SCN; 4×S5K; |
|
| HUMAN IMMUNOPROTEASOME 20S PARTICLE IN COMPLEX WITH [2-(3-ethylphenyl)-1-[(2S)-3-phenyl-2-[(pyrazin… | |
Heteromer O14818; P20618; P25786; P25788; P25789; P28062; P28065; P28066; P28070; P40306; P49720; P49721; P60900; | 5-233 | 100 | 5×SO4; 6×NA; 6×SKN; |
|
| Human Immunoproteasome 20S particle in complex with compound 1 | |
Heteromer O14818; P20618; P25786; P25788; P25789; P28062; P28065; P28066; P28070; P40306; P49720; P49721; P60900; | 5-233 | 100 | 3×SCN; 12×NA; 4×HUJ; |
|
| Human 20S proteasome with MG-132 | |
Heteromer O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | 4-232 | 100 | 6×LDZ; |
|
| human 20S proteasome | |
Heteromer O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | 4-232 | 100 | |
|
| Human 20S proteasome core particle | |
Heteromer O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | 4-232 | 100 | |
|
| 20S+monoUb-CyclinB1-NT (S2) | |
Heteromer O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | 4-232 | 100 | |
|
| Human 20S Proteasome | |
Heteromer O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | 4-232 | 100 | |
|
| Human PA28-20S proteasome complex | |
Heteromer O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q06323; Q99436; Q9UL46; | 4-232 | 100 | |
|
| Human 20S proteasome assembly intermediate structure 4 | |
Heteromer O14818; O95456; P20618; P25786; P25788; P25789; P28066; P28074; P49720; P49721; P60900; Q969U7; Q99436; Q9Y244; | 5-233 | 100 | |
|
| Human PA28-20S-PA28 proteasome complex | |
Heteromer O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q06323; Q99436; Q9UL46; | 4-232 | 100 | |
|
| Human PA28-20S (PA28-4a3b) | |
Heteromer O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q06323; Q99436; Q9UL46; | 4-232 | 100 | |
|
| Human preholo proteasome 20S core particle | |
Heteromer O14818; O95456; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q969U7; Q99436; Q9Y244; | 4-232 | 100 | |
|
| Human proteasome 20S core particle | |
Heteromer O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | 5-233 | 100 | |
|
| Structure of human 20S proteasome with bound MPI-5 | |
Heteromer O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | 5-233 | 100 | 2×YHD; |
|
| 20S+monoUb-CyclinB1-NT (S1) | |
Heteromer O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | 5-232 | 100 | |
|
| Bovine 20S immunoproteasome in complex with two human PA28alpha-beta activators | |
Heteromer P33672; Q06323; Q2TBX6; Q2YDE4; Q3SZC2; Q3T0T1; Q3T0X5; Q3T0Y5; Q3T108; Q3T112; Q3ZBG0; Q3ZCK9; Q58DU5; Q5E987; Q5E9K0; Q9UL46; | 7-234 | 100 | |
|
| Bovine 20S proteasome, untreated | |
Heteromer P33672; Q2TBP0; Q2TBX6; Q2YDE4; Q32KL2; Q3MHN0; Q3T0X5; Q3T0Y5; Q3T108; Q3ZBG0; Q3ZCK9; Q58DU5; Q5E987; Q5E9K0; | 5-232 | 100 | |
|
| Human 20S proteasome assembly structure 1 | |
Heteromer O14818; O95456; P25786; P25788; P25789; P28066; P60900; Q5JS54; Q969U7; Q99436; Q9BT73; Q9Y244; | 6-233 | 100 | |
|
| Human proteasome alpha ring assembly intermediate | |
Heteromer O14818; O95456; P25786; P25788; P25789; P28066; P60900; Q5JS54; Q969U7; Q9BT73; | 5-232 | 100 | |
|
| Human 20S proteasome bound to an engineered 11S (PA26) activator | |
Heteromer O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; Q9U8G2; | 8-234 | 100 | |
|
| canine immunoproteasome 20S subunit in complex with compound 1 | |
Heteromer A0A8C0M3N7; A0A8C0MRG6; A0A8C0N5D2; A0A8C0NHD1; A0A8C0QE86; A0A8C0QRK5; A0A8C0R9W7; A0A8C0SLB3; A0A8C0SR54; A0A8C0TD63; A0A8C0TIY6; A0A8I3PML0; Q5W412; Q5W416; | 5-230 | 100 | 4×A1L0C; |
|
| canine immunoproteasome 20S subunit in complex with compound 2 | |
Heteromer A0A8C0M3N7; A0A8C0MRG6; A0A8C0N5D2; A0A8C0NHD1; A0A8C0QE86; A0A8C0QRK5; A0A8C0R9W7; A0A8C0SLB3; A0A8C0SR54; A0A8C0T7K4; A0A8C0TD63; A0A8C0TIY6; A0A8I3PML0; Q5W416; | 5-230 | 100 | 4×A1L0D; |
|
| Cryo-EM reveals the conformation of a substrate analogue in the human 20S proteasome core | |
Heteromer O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | 6-227 | 100.0 | 6×KNM; |
|
| Human 20S-PA200 Proteasome Complex | |
Heteromer O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q14997; Q99436; | 19-232 | 100 | 2×IHP; 2×K0W; |
|